Private Practice

Partner, Goldman Ismail Tomaselli Brennan & Baum LLP

Partner, Bartlit Beck Herman Palenchar & Scott LLP

Associate, Bartlit Beck Herman Palenchar & Scott LLP


Northwestern University Law School (J.D., cum laude)

University of Michigan (B.A., Economics)


Bar & Court Admissions

State of Illinois

U.S. Court of Appeals for the Fifth Circuit

U.S. District Court for the Northern District of Illinois (including Trial Bar)

Photo of Andrew L. Goldman

Andrew L. Goldman

Partner / Chicago

“Clients note that Andrew Goldman has an excellent demeanor and is a brilliant legal strategist.” “He is an experienced trial lawyer,” “who is able to take very complex facts and break them down to simplicity.” -Chambers USA (ranked 2015-2019)

Andrew Goldman “is a fantastic lawyer, very hard-working and smart." He is "extraordinary.” -The Legal 500 (mentioned 2009-2015, 2017)

Andy Goldman has distinguished himself as a trial lawyer who has what it takes to win high-profile complex products liability and general commercial cases. From the outset, Andy litigates each case with a focus on trial in order to develop a credible and persuasive theory of the case that jurors can understand. Clients value the breadth and depth of his litigation experience and rely on his expertise to identify, prepare, defend, and examine key witnesses in depositions and at trial. Complementing his legal acumen is Andy's keen ability to connect with judges, juries, and witnesses for both his client and those testifying for the other side.

Andy has built a well-earned reputation for successfully navigating the toughest cases to win on behalf of Fortune 500 and multi-national companies. Chambers USA confirms Andy "is an experienced litigator, routinely retained by high-profile pharmaceuticals to serve as lead trial counsel in product liability cases." As reported by The Legal 500, “commentators have been very impressed.” Andy “receives glowing feedback from clients” who say he is "extraordinary," a “very hardworking, very skilled trial lawyer.” Andy's trials – spanning several decades – have been covered in The American Lawyer, Wall Street Journal, The New York Times, and Law360.

Of Note

Representative Litigation

West v. Bayer HealthCare Pharmaceuticals Inc.

Lead counsel for Bayer in litigation involving claims of infection arising from allegedly contaminated components of a self-administered Betaseron® injection kit used to treat multiple sclerosis.

Sybron Canada Holdings, Inc. et al. v. Gerald A. Niznick et al.

Lead trial counsel for Danaher Corp. joint venture companies in a breach of contract and fiduciary duty action against the joint ventures’ minority shareholders pending in New York state court’s Commercial Division. After approximately fifty days of deposition testimony and a two-week bench trial, the Court granted complete relief to Danaher and the joint venture companies, ruling that the minority shareholders had engaged in conduct that triggered two contractual buy-out options.  The Court also rejected all of the minority shareholders’ counterclaims against Danaher and the joint venture companies from which the shareholders had originally sought over 100 million dollars in damages.   Obtained dismissal of two related cases filed in California state court by the minority shareholders.

In re Ethicon, Inc., Pelvic Repair System Products Liability Litigation

Counsel for Johnson & Johnson and Ethicon in federal MDL concerning prescription pelvic mesh products used for the treatment of pelvic organ prolapse and stress incontinence. Deposed key experts and treating physicians.

Federal Trade Commission v. Staples, Inc. and Office Depot, Inc.

Represented Staples, Inc. in its proposed $6.3 billion acquisition of Office Depot, Inc., which the Federal Trade Commission moved to enjoin in D.C. federal court. Conducted deposition of key third-party witness for FTC located outside trial subpoena range.

Fosamax Litigation

Trial counsel for Merck & Co., Inc. in litigation concerning Fosamax®, a prescription drug used for the treatment and prevention of osteoporosis and other bone disorders. 

Vioxx Litigation

Trial counsel for Merck & Co., Inc. in individual and government actions claiming Merck’s withdrawn anti-inflammatory medication Vioxx® caused heart attacks and other cardiovascular problems.

Magnevist Contrast Dye Litigation

Lead trial counsel for Bayer in federal MDL and state litigation regarding Bayer's Magnevist® contrast dye. Plaintiffs claim that they developed a progressive, incurable disease known as nephrogenic systemic fibrosis as a result of exposure to Bayer's gadolinium-based contrast agent Magnevist® and other contrast agents during MRI procedures.

Servcor International, Inc. v. Bayer MaterialScience LLC

Lead counsel for Bayer MaterialScience LLC in complex, multi-party commercial dispute in Florida state court. Following dissolution of the parties’ business relationship in the commercial roofing market, plaintiff sought damages over $100 million for breach of contract, breach of fiduciary duty, negligence, fraud, conspiracy, and other tort and contract claims. After Bayer prevailed on two motions to dismiss, plaintiff voluntarily dismissed all claims with prejudice.


Law360, Q&A with Goldman Ismail’s Andy Goldman (April 2013)

Andrew L. Goldman & J. Walter Sinclair, Advisability and Practical Considerations of Court-Imposed Time Limits on Trial, Defense Counsel Journal, Vol. 79, No. 4 (October 2012)